Intermediate-dose intramuscular methylprednisolone acetate in the treatment of rheumatic disease.
نویسندگان
چکیده
منابع مشابه
Intermediate-dose intramuscular methylprednisolone acetate in the treatment of rheumatic disease.
Treatment with a high-dose, intravenous bolus of methylprednisolone has been reported in numerous cases of rheumatic diseases. The optimal routes of administration, dosage, dosage interval, and other factors are unknown. This report describes uncontrolled clinical observations with a single dose of 320 mg of intramuscular methylprednisolone acetate in patients with rheumatic disease (12 with rh...
متن کاملIntramuscular methotrexate in inflammatory rheumatic disease.
Hutchinson et al concluded that prolonged heavy cigarette smoking, but not smoking itself, is strongly associated with rheumatoid arthritis (RA), particularly in patients without a positive family history. The authors proposed that increased rheumatoid factor (RF) production resulting from heavy smoking exposures explains, in part, the relation of increasing cumulative pack years smoked and the...
متن کاملthe effect of authentic listening materials on the listening proficiency of efl learners in the intermediate level
having conducted the experiment and analysed the data, the researcher computed the groups mean scores and variances for the test relating to the research question. as the final atep, a t-test was conodonted for the hypothesis. as noted earlier, the significance level was determined at .05 and .01 respectively. the observed t-value was higher than the critical t-value at. 5 and .01 levels. conse...
15 صفحه اولTreatment of polymyalgia rheumatica with intramuscular injections of depot methylprednisolone.
Although the treatment of patients with polymyalgia rheumatica by corticosteroids given by mouth is effective, it is often accompanied by multiple side effects. Various studies have shown that the steroid related complications are proportional to the cumulative dose of steroids administered. In a prospective study of 16 patients with polymyalgia rheumatica the effects of regular intramuscular i...
متن کاملProgress in the treatment of rheumatic disease.
The progress in defining the immunological and inflammatory mechanisms that lead to the progressive joint destruction in rheumatoid arthritis (RA) [1,2] has led to the development of new inhibitory drugs. Large randomized controlled trials have shown the efficacy of the new treatments and led to the recent approval of several new drugs by American and European health authorities. These are the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of the Rheumatic Diseases
سال: 1983
ISSN: 0003-4967
DOI: 10.1136/ard.42.3.308